ACH Share Price Performance
US$2.46
-12.11 (-83.12%)
59.8% undervalued intrinsic discount
US$6.12
Fair Value
Price US$2.46
AnalystConsensusTarget US$6.12
AnalystLowTarget US$4.00
AnalystHighTarget US$7.00
Fair ValueUS$6.12
Share Pricen/a
Accendra Health, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
ACH Community Narratives
AN
Fair Value US$6.12 59.8% undervalued intrinsic discount
Patient Direct Model Will Transform Home-Based Health Care Market
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
Fair Value US$4 38.5% undervalued intrinsic discount
Rising Healthcare Pressures Will Exacerbate Patient Direct Vulnerabilities
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value US$7 64.9% undervalued intrinsic discount
Home-based Care Expansion Will Drive Secular Growth
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Rising Healthcare Pressures Will Exacerbate Patient Direct Vulnerabilities
Key Takeaways Narrow operational focus and rising competition heighten revenue unpredictability and vulnerability to industry shifts that bypass traditional distributors. Persistent debt burden, margin pressures, and cost volatility limit financial flexibility and threaten sustainable earnings growth.Read more
30
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$4
38.5% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
-49.3% p.a.
Profit Margin
5.45%
Future PE
5.73x
Price in 2028
US$5.65
Home-based Care Expansion Will Drive Secular Growth
Key Takeaways Leadership in home-based care and high-growth medical categories positions Owens & Minor for strong, recurring revenue and margin gains. Investments in automation, IT, and focused M&A enhance operating leverage, supporting faster cash flow growth and increased long-term contract wins.Read more
12
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$7
64.9% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
-41.9% p.a.
Profit Margin
0.46%
Future PE
78.74x
Price in 2028
US$9.79
Patient Direct Model Will Transform Home-Based Health Care Market
Key Takeaways Focusing on higher-margin home-based care and divesting lower-growth segments enhances long-term growth, margin expansion, and free cash flow. Investments in technology, operational efficiency, and targeted acquisitions improve profitability and support ongoing balance sheet strengthening.Read more
72
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
US$6.12
59.8% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
-34.54% p.a.
Profit Margin
0.67%
Future PE
32.78x
Price in 2028
US$8.54
Trending Discussion
Recently Updated Narratives
AN
OMI: Turnaround Progress And Rising Margins Will Drive Future Upside Potential
Fair Value: US$4 38.5% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Home-based Care Expansion Will Drive Secular Growth
Fair Value: US$7 64.9% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Patient Direct Model Will Transform Home-Based Health Care Market
Fair Value: US$6.12 59.8% undervalued intrinsic discount
5 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Accendra Health, Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -5.65
- 20.78%
- -4.06%
- -492.5%
About ACH
- Founded
- 1882
- Employees
- 23200
- CEO
- WebsiteView website
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians’ practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
